Hypertrophic cardiomyopathy associated with oral corticosteroid therapy for palpebral hemangioma;Cardiomyopathie hypertrophique compliquant une corticothérapie orale pour hémangiome palpébral

Annales de Dermatologie et de Venereologie

Volumn 131, Issue 3, 2004, Pages 263-265

  Nina, K Some ^a   Lorette, G ^a   Chantepie, A ^b   Villerette, C ^c   Machet, L ^a  

^a UNIVERSITY HOSPITAL OF TOURS   (France)

^b Centre de Pediatrie Clocheville   (France)

^c Arc en ciel   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BETAMETHASONE; CORTICOSTEROID; PREDNISONE;

ARTICLE; CASE REPORT; CORTICOSTEROID THERAPY; DOSE TIME EFFECT RELATION; DRUG EFFICACY; DRUG TOLERANCE; DRUG WITHDRAWAL; ECHOCARDIOGRAPHY; EYELID TUMOR; FEMALE; HEART MURMUR; HEMANGIOMA; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY; INFANT; PATIENT MONITORING; REMISSION; RISK ASSESSMENT; SYSTEMIC THERAPY; VASCULAR DISEASE;

EID: 1942466658     PISSN: 01519638     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0151-9638(04)93589-2     Document Type: Article

References (4)

1. Bennet ML, Fleischer AB Jr, Chamlin SL, Frieden IJ. Oral corticosteroid use is effective for cutaneous hemangiomas: an evidence-based evaluation. Arch Dermatol 2001;137:1208-13.
2. Thédenat B, Léauté-Labrèze C, Boralevi F, Roul S, Labré L, Malière V, Taieb A. Surveillance tensionnelle des nourrissons traités par corticothérapie géné rale pour hémangiome. Ann Dermatol Venereol 2002;129:183-5.
3. Pokorny JJ, Roth F, Balfour I, Rinehart G. An unusual complication of treatment of hemangioma. Ann Plast Surg 2002;48:83-7.
4. Lhasbellaoui F, Faure C, Magnier S, Guillonneau M, Cézard JP, Navarro J et al. Myocardiopathie hypertrophique compliquant une corticothérapie prolongée pour rectocolite hémorragique. Arch Pediatr 1997;4:48-51.